Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer’s disease

References

• Anwar F, Saleem U, Rehman AU, et al. (2021). Toxicity evaluation of the naphthalen-2-yl 3,5-dinitrobenzoate: a drug candidate for Alzheimer disease. Front Pharmacol :1.
   Web of Science ®Google Scholar
• Baranowska-Wójcik E, Szwajgier D. (2020). Alzheimer’s disease: review of current nanotechnological therapeutic strategies. Expert Rev Neurother :271–9.
   PubMed Web of Science ®Google Scholar
• Cai N, Chen J, Bi D, et al. (2020). Specific degradation of endogenous tau protein and inhibition of tau fibrillation by tanshinone IIA through the ubiquitin–proteasome pathway. J Agric Food Chem 29:2054–62.
   Web of Science ®Google Scholar
• Candela P, Saint-Pol J, Kuntz M, et al. (2015). In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes. Brain Res 1594:15–26.
   PubMed Web of Science ®Google Scholar
• Carita AC, Eloy JO, Chorilli M, et al. (2018). Recent advances and perspectives in liposomes for cutaneous drug delivery. Curr Med Chem 25:606–35.
   PubMed Web of Science ®Google Scholar
• Chen C, Duan Z, Yuan Y, et al. (2017). Peptide-22 and cyclic RGD functionalized liposomes for glioma targeting drug delivery overcoming BBB and BBTB. ACS Appl Mater Interfaces 9:5864–73.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Zheng HY, Huang XX, et al. (2016). Neuroprotective effects of icariin on brain metabolism, mitochondrial functions, and cognition in triple-transgenic Alzheimer’s disease mice. CNS Neurosci Ther 22:63–73.
   PubMed Web of Science ®Google Scholar
• Dos Santos Rodrigues B, Lakkadwala S, Kanekiyo T, Singh J. (2020). Dual-modified liposome for targeted and enhanced gene delivery into mice brain. J Pharmacol Exp Ther 374:354–65.
   PubMed Web of Science ®Google Scholar
• Duro-Castano A, Borrás C, Herranz-Pérez V, et al. (2021). Targeting Alzheimer’s disease with multimodal polypeptide-based nanoconjugates. Sci Adv 7:eabf9180.
   PubMed Web of Science ®Google Scholar
• Endo-Takahashi Y, Kurokawa R, Sato K, et al. (2021). Ternary complexes of pDNA, neuron-binding peptide, and PEGylated polyethyleneimine for brain delivery with nano-bubbles and ultrasound. Pharmaceutics 13:1003.
   PubMed Web of Science ®Google Scholar
• Eratne D, Loi SM, Farrand S, et al. (2018). Alzheimer’s disease: clinical update on epidemiology, pathophysiology and diagnosis. Aust Psychiatry 26:347–57.
   PubMed Web of Science ®Google Scholar
• Fang XX, Sun GL, Zhou Y, et al. (2018). TGF-β1 protection against Aβ1-42-induced hippocampal neuronal inflammation and apoptosis by TβR-I. Neuroreport 29:141–6.
   PubMed Web of Science ®Google Scholar
• Formicola B, Cox A, Dal Magro R, et al. (2019). Nanomedicine for the treatment of Alzheimer’s disease. J Biomed Nanotechnol 15:1997–2024.
   PubMed Web of Science ®Google Scholar
• Gao H. (2016). Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B 6:268–86.
   PubMed Web of Science ®Google Scholar
• Geng L, Liu W, Chen Y. (2019). Tanshinone IIA attenuates Aβ-induced neurotoxicity by down-regulating COX-2 expression and PGE2 synthesis via inactivation of NF-κB pathway in SH-SY5Y cells. J Biol Res 26:15.
   Web of Science ®Google Scholar
• Gomaa AA, Makboul RM, El-Mokhtar MA, et al. (2019). Terpenoid-rich Elettaria cardamomum extract prevents Alzheimer-like alterations induced in diabetic rats via inhibition of GSK3β activity, oxidative stress and pro-inflammatory cytokines. Cytokine 113:405–16.
   PubMed Web of Science ®Google Scholar
• Han G, Bai K, Yang X, et al. (2022). “Drug-carrier” synergy therapy for amyloid-β clearance and inhibition of tau phosphorylation via biomimetic lipid nanocomposite assembly. Adv Sci e2106072.
   Google Scholar
• He C, Wang Z, Shi J. (2020). Pharmacological effects of icariin. Adv Pharmacol 87:179–203.
   PubMedGoogle Scholar
• Huang N, Li Y, Zhou Y, et al. (2019). Neuroprotective effect of tanshinone IIA-incubated mesenchymal stem cells on Aβ25-35-induced neuroinflammation. Behav Brain Res 365:48–55.
   PubMed Web of Science ®Google Scholar
• Kong L, Li XT, Ni YN, et al. (2020). Transferrin-modified osthole PEGylated liposomes travel the blood–brain barrier and mitigate Alzheimer’s disease-related pathology in APP/PS-1 mice. Int J Nanomedicine 15:2841–58.
   PubMed Web of Science ®Google Scholar
• Lakkadwala S, Dos Santos Rodrigues B, Sun C, Singh J. (2019). Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma. J Control Release 307:247–60.
   PubMed Web of Science ®Google Scholar
• Lei T, Yang Z, Xia X, et al. (2021). A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease. Acta Pharm Sin B 11:4032–44.
   PubMed Web of Science ®Google Scholar
• Li F, Dong HX, Gong QH, et al. (2015). Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice. Neuroscience 304:29–35.
   PubMed Web of Science ®Google Scholar
• Li S, Xu Q, Zhao L, et al. (2019). Angiopep-2 modified cationic lipid-poly-lactic-co-glycolic acid delivery temozolomide and DNA repair inhibitor Dbait to achieve synergetic chemo-radiotherapy against glioma. J Nanosci Nanotechnol 19:7539–45.
   PubMed Web of Science ®Google Scholar
• Liu SY, Lu S, Yu XL, et al. (2018a). Fruitless wolfberry-sprout extract rescued cognitive deficits and attenuated neuropathology in Alzheimer’s disease transgenic mice. Curr Alzheimer Res 15:856–68.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang Y, Zheng X, et al. (2018b). Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice. J Neuroinflammation 15:112.
   PubMed Web of Science ®Google Scholar
• Lu BL, Li J, Zhou J, et al. (2016). Tanshinone IIA decreases the levels of inflammation induced by Aβ1-42 in brain tissues of Alzheimer’s disease model rats. Neuroreport 27:883–93.
   PubMed Web of Science ®Google Scholar
• Lu S, Wei X, Zhang H, et al. (2021). Protective effect of 2-dodecyl-6-methoxycyclohexa-2, 5-diene-1, 4-dione, isolated from Averrhoa carambola L., against Aβ1-42-induced apoptosis in SH-SY5Y cells by reversing Bcl-2/Bax ratio. Psychopharmacology 238:193–200.
   PubMed Web of Science ®Google Scholar
• Ma D, Zhao L, Zhang L, et al. (2021). Icariin promotes survival, proliferation, and differentiation of neural stem cells in vitro and in a rat model of Alzheimer’s disease. Stem Cells Int 2021:9974625.
   PubMed Web of Science ®Google Scholar
• Ma HH, Wan C, Zhang LD, et al. (2022). Sodium tanshinone IIA sulfonate improves cognitive impairment via regulating Aβ transportation in AD transgenic mouse model. Metab Brain Dis 37:989–1001.
   PubMed Web of Science ®Google Scholar
• Morales-Zavala F, Arriagada H, Hassan N, et al. (2017). Peptide multifunctionalized gold nanorods decrease toxicity of β-amyloid peptide in a Caenorhabditis elegans model of Alzheimer’s disease. Nanomedicine 13:2341–50.
   PubMed Web of Science ®Google Scholar
• Pahrudin Arrozi A, Shukri SNS, Wan Ngah WZ, et al. (2020). Comparative effects of alpha- and gamma-tocopherol on mitochondrial functions in Alzheimer’s. Sci Rep 10:8962.
   PubMed Web of Science ®Google Scholar
• Panza F, Lozupone M, Logroscino G, Imbimbo BP. (2019). A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease. Nat Rev Neurol 15:73–88.
   PubMed Web of Science ®Google Scholar
• Poovaiah N, Davoudi Z, Peng H, et al. (2018). Treatment of neurodegenerative disorders through the blood–brain barrier using nanocarriers. Nanoscale 10:16962–83.
   PubMed Web of Science ®Google Scholar
• Ross C, Taylor M, Fullwood N, Allsop D. (2018). Liposome delivery systems for the treatment of Alzheimer’s disease. Int J Nanomedicine 13:8507–22.
   PubMed Web of Science ®Google Scholar
• Ruan S, Zhou Y, Jiang X, Gao H. (2021). Rethinking CRITID procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization, and drug release. Adv Sci 8:2004025.
   Web of Science ®Google Scholar
• Shah S, Dhawan V, Holm R, et al. (2020). Liposomes: advancements and innovation in the manufacturing process. Adv Drug Deliv Rev 154–155:102–22.
   PubMed Web of Science ®Google Scholar
• Sheng C, Xu P, Zhou K, et al. (2017). Icariin attenuates synaptic and cognitive deficits in an Aβ1-42-induced rat model of Alzheimer’s disease. Biomed Res Int 2017:7464872.
   PubMed Web of Science ®Google Scholar
• Song P, Song N, Li L, et al. (2021). Angiopep-2-modified carboxymethyl chitosan-based pH/reduction dual-stimuli-responsive nanogels for enhanced targeting glioblastoma. Biomacromolecules 22:2921–34.
   PubMed Web of Science ®Google Scholar
• Storck SE, Pietrzik CU. (2017). Endothelial LRP1 – a potential target for the treatment of Alzheimer’s disease: theme: drug discovery, development and delivery in Alzheimer’s disease Guest Editor: Davide Brambilla. Pharm Res 34:2637–51.
   PubMed Web of Science ®Google Scholar
• Tönnies E, Trushina E. (2017). Oxidative stress, synaptic dysfunction, and Alzheimer’s disease. J Alzheimers Dis 57:1105–21.
   PubMed Web of Science ®Google Scholar
• Wang X, Xiong Z, Liu Z, et al. (2018). Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma. Sci Rep 8:12827.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Q, Li J, et al. (2019). Glutamine improves oxidative stress through the Wnt3a/β-catenin signaling pathway in Alzheimer’s disease in vitro and in vivo. Biomed Res Int 2019:4690280.
   PubMed Web of Science ®Google Scholar
• Xu PX, Wang SW, Yu XL, et al. (2014). Rutin improves spatial memory in Alzheimer’s disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation. Behav Brain Res 264:173–80.
   PubMed Web of Science ®Google Scholar
• Yu C, Liu H, Guo C, et al. (2022). Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis. Drug Deliv 29:454–65.
   PubMed Web of Science ®Google Scholar
• Yu Y, Pang Z, Lu W, et al. (2012). Self-assembled polymersomes conjugated with lactoferrin as novel drug carrier for brain delivery. Pharm Res 29:83–96.
   PubMed Web of Science ®Google Scholar
• Zhang H, Su Y, Sun Z, et al. (2021). Ginsenoside Rg1 alleviates Aβ deposition by inhibiting NADPH oxidase 2 activation in APP/PS1 mice. J Ginseng Res 45:665–75.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wu HH, Wang Y, et al. (2016). Neural stem cell transplantation decreases neuroinflammation in a transgenic mouse model of Alzheimer’s disease. J Neurochem 136:815–25.
   PubMed Web of Science ®Google Scholar
• Zheng X, Shao X, Zhang C, et al. (2015). Intranasal H102 peptide-loaded liposomes for brain delivery to treat Alzheimer’s disease. Pharm Res 32:3837–49.
   PubMed Web of Science ®Google Scholar
• Zhou L, Poon CC, Wong KY, et al. (2020). Prenylflavonoid icariin induces estrogen response element-independent estrogenic responses in a tissue-selective manner. J Endocr Soc 4:bvz025.
   PubMed Web of Science ®Google Scholar
• Zhou R, Chen LL, Yang H, et al. (2021). Effect of high cholesterol regulation of LRP1 and RAGE on Aβ transport across the blood–brain barrier in Alzheimer’s disease. Curr Alzheimer Res 18:428–42.
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhang Y, Chen X, et al. (2021). Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB. Biochem Biophys Res Commun 534:902–7.
   PubMed Web of Science ®Google Scholar
• Zu Y, Mu Y, Li Q, et al. (2019). Icariin alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis. J Orthop Surg Res 14:307.
   PubMed Web of Science ®Google Scholar